Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Group C streptococcal glomerulonephritis

A Sukonthaman, P Nanthapisud, P Phanuphak

    Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
    |July 1, 1981
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study.

    Clinical pharmacology and therapeutics·2015
    Same author

    Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database.

    Journal of the International Association of Providers of AIDS Care·2013
    Same author

    Assessing adherence in Thai patients taking combination antiretroviral therapy.

    International journal of STD & AIDS·2012
    Same author

    Determinants of epidermal nerve fibre density in antiretroviral-naïve HIV-infected individuals.

    HIV medicine·2012
    Same author

    Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais.

    HIV medicine·2011
    Same author

    Prediction of response to antiretroviral therapy by human experts and by the EuResist data-driven expert system (the EVE study).

    HIV medicine·2010